New Zealand - engelsk - Medsafe (Medicines Safety Authority)

viatris limited - eplerenone 50mg; eplerenone 50mg - film coated tablet - 50 mg - active: eplerenone 50mg excipient: croscarmellose sodium hypromellose lactose monohydrate magnesium stearate microcrystalline cellulose opadry yellow purified talc purified water   sodium laurilsulfate active: eplerenone 50mg excipient: croscarmellose sodium hypromellose lactose monohydrate magnesium stearate microcrystalline cellulose opadry yellow purified talc purified water   sodium laurilsulfate - inspra is indicated to reduce the risk of cardiovascular death in combination with standard therapy in patients who have evidence of heart failure and left ventricular impairment within 3 to 14 days of an acute myocardial infarction.

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - cyproterone acetate 100mg;  ;   - tablet - 100 mg - active: cyproterone acetate 100mg     excipient: croscarmellose sodium lactose monohydrate magnesium stearate microcrystalline cellulose povidone - in men · antiandrogen treatment in inoperable carcinoma of the prostate

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - cyproterone acetate 50mg - tablet - 50 mg - active: cyproterone acetate 50mg excipient: lactose monohydrate magnesium stearate maize starch sodium starch glycolate starch

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - cyproterone acetate 50mg;  ;   - tablet - 50 mg - active: cyproterone acetate 50mg     excipient: croscarmellose sodium lactose monohydrate magnesium stearate microcrystalline cellulose povidone - in men · antiandrogen treatment in inoperable carcinoma of the prostate

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - medroxyprogesterone acetate 10mg;   - tablet - 10 mg - active: medroxyprogesterone acetate 10mg   excipient: calcium stearate lactose monohydrate liquid paraffin maize starch purified talc purified water sucrose - provera low dosage (2.5mg, 5mg and 10mg tablets) are indicated for: · diagnosis of primary and secondary amenorrhoea · treatment of dysfunctional (anovulatory) uterine bleeding · opposition of endometrial effects of estrogen in menopausal women being treated with estrogen (hormone replacement therapy [hrt]) · treatment of endometriosis.

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - medroxyprogesterone acetate 2.5mg;   - tablet - 2.5 mg - active: medroxyprogesterone acetate 2.5mg   excipient: calcium stearate lactose monohydrate liquid paraffin maize starch purified talc purified water sucrose sunset yellow fcf - provera low dosage (2.5mg, 5mg and 10mg tablets) are indicated for: · diagnosis of primary and secondary amenorrhoea · treatment of dysfunctional (anovulatory) uterine bleeding · opposition of endometrial effects of estrogen in menopausal women being treated with estrogen (hormone replacement therapy [hrt]) · treatment of endometriosis.

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - medroxyprogesterone acetate 5mg;   - tablet - 5 mg - active: medroxyprogesterone acetate 5mg   excipient: calcium stearate indigo carmine lactose monohydrate liquid paraffin maize starch purified talc purified water sucrose - provera low dosage (2.5mg, 5mg and 10mg tablets) are indicated for: · diagnosis of primary and secondary amenorrhoea · treatment of dysfunctional (anovulatory) uterine bleeding · opposition of endometrial effects of estrogen in menopausal women being treated with estrogen (hormone replacement therapy [hrt]) · treatment of endometriosis.

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - medroxyprogesterone acetate 100mg;   - tablet - 100 mg - active: medroxyprogesterone acetate 100mg   excipient: docusate sodium gelatin hydrolysate isopropyl alcohol macrogol 400 magnesium stearate maize starch microcrystalline cellulose purified water sodium benzoate sodium starch glycolate - provera 100mg and 200mg tablets are indicated as adjunctive and/or palliative treatment of recurrent and/or metastatic endometrial or renal carcinoma and, in the treatment of hormonally-dependent, recurrent breast cancer in post-menopausal women.

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - medroxyprogesterone acetate 200mg;   - tablet - 200 mg - active: medroxyprogesterone acetate 200mg   excipient: docusate sodium gelatin hydrolysate isopropyl alcohol macrogol 400 magnesium stearate maize starch microcrystalline cellulose purified water sodium benzoate sodium starch glycolate - provera 100mg and 200mg tablets are indicated as adjunctive and/or palliative treatment of recurrent and/or metastatic endometrial or renal carcinoma and, in the treatment of hormonally-dependent, recurrent breast cancer in post-menopausal women.

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

pharmacia limited company trading as pharmacia - medroxyprogesterone acetate 400mg;   - tablet - 400 mg - active: medroxyprogesterone acetate 400mg   excipient: docusate sodium gelatin hydrolysate isopropyl alcohol macrogol 400 magnesium stearate maize starch microcrystalline cellulose purified water sodium benzoate sodium starch glycolate